Medicine Recommendations

Following bariatric surgery performed privately. 

Following a sleeve gastrectomy

Asymptomatic patients that are at high or normal risk of vitamin D deficiency

Prophylaxis or maintenance, following treatment of deficiency and insufficiency for symptomatic individuals that are at high or normal risk of vitamin D deficiency

For the correction of deficiency and insufficiency in high-risk, symptomatic patients as a short-course treatment. 

For additional prescribing information see Vitamin D Prescriber Resources in our Clinical Resources section

Nicotine Replacement Therapy

Please note: eVoke and Voke are different products. For eVoke see 'Electronic-cigarettes (e-cigarettes)'

Major depressive episodes

NICE TA367 - Vortioxetine for treating major depressive episodes

Prevention of stroke and systemic embolism in non-valvular atrial fibrillation

 Treatment of venous thromboembolism

Influenza treatment & prophylaxis

NICE TA158 - Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza

NICE TA168 - Amantadine, oseltamivir and zanamivir for the treatment of influenza

Glucocorticoid-induced osteoporosis

NICE TA 464 - Bisphosphonates for treating osteoporosis

MHRA Drug Safety Update - Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal

MHRA Drug Safety Update - Bisphosphonates: atypical femoral fractures

Osteoporosis (NICE TA464)

NICE TA 464 - Bisphosphonates for treating osteoporosis

MHRA Drug Safety Update - Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal

MHRA Drug Safety Update - Bisphosphonates: atypical femoral fractures

Short term management of insomnia (NICE TA77)

NICE TA 77 - Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

Epilepsy

MHRA Drug Safety Update - Antiepileptic drugs: updated advice on switching between different manufacturers’ products

Migraine prophylaxis 

Short term management of insomnia (NICE TA77)

NICE TA 77 - Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Schizophrenia and paranoid psychosis

Short term management of acute psychosis, mania or exacerbations of chronic psychosis

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

For maintenance for treatment of schizophrenia and paranoid Psychosis